Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains

Journal of Neural Transmission

Volumn 107, Issue 8-9, 2000, Pages 1085-1097

  Blennow, K ^a   Bogdanovic, N ^b   Heilig, M ^b   Grenfeldt, B ^a   Karlsson, I ^a   Davidsson, P ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Limbic system; rab3a; Schizophrenia; Synapse; Synaptic; Thalamus

Indexed keywords

MONOCLONAL ANTIBODY;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENTAL DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSYCHOSIS; SCHIZOPHRENIA; THALAMUS;

ADULT; ANTERIOR THALAMIC NUCLEI; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDIODORSAL THALAMIC NUCLEUS; MIDDLE AGE; RAB3A GTP-BINDING PROTEIN; SCHIZOPHRENIA; SUPPORT, NON-U.S. GOV'T; SYNAPSES;

EID: 0033794278     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070054     Document Type: Article

References (50)

1. Projections of the amygdala to the thalamus in the cynomolgus monkey
2. Subcortical afferents to the hippocampal formation in the monkey
3. SPECT asymmetry of left temporal lobe in hallucinating schizophrenics of the undifferentiated type
4. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging
5. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia
6. The duality of the cingulate gyrus in monkey: Neuroanatomical studies and functional hypothesis
7. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia
8. Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele
9. Synaptic degeneration in thalamus in schizophrenia
10. The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia
11. Recent advance in the neuropathology of schizophrenia
12. PET and MRI of the thalamus in never-medicated patients with schizophrenia
13. Regional brain metabolism during auditory hallucinations in chronic schizophrenia
14. Schizophrenia and anteroventral thalamic nucleus: Selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons
15. Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: A new biochemical marker for synaptic pathology in Alzheimer's disease?
16. Increased temporal lobe glucose use in chronic schizophrenic patients
17. Left globus pallidus abnormality in never-medicated patients with schizophrenia
18. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography
19. Striatal synaptophysin expression and haloperidol-induced synaptic plasticity
20. Rab3 is a small GTP-binding protein exclusively localised to synaptic vesicles
21. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia
22. Left hemisphere dysfunction and left hemisphere overactivation in schizophrenia
23. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography
24. Laterality and frontality of cerebral blood flow and metabolism in schizophrenia: Relationship to symptom specificity
25. Localization of putative cholinergic neurons innervating the anteroventral thalamus
26. Nuclear organization and chief connections of the primate hypothalamus
27. Synaptic vesicle traffic: Rush hour in the nerve terminal
28. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
29. Cortical development and thalamic pathology in schizophrenia
30. The thalamic afferents to the inferior parietal lobule of the rhesus monkey
31. The diencephalon in schizophrenia: Evidence for reduced thickness of the periventricular grey matter
32. Neurochemistry and neuroendocrinology of schizophrenia: A selective review
33. Protein measurement with the folin phenol reagent
34. Reduced number of mediodorsal thalamic neurons in schizophrenia
35. Association of rab3a with synaptic vesicles at late stages of the secretory pathway
36. Electron microscopic study on schizophrenia: Mechanism of pathological changes
37. Synaptogenesis in the rat suprachiasmatic nucleus demonstrated by electron microscopy and synapsin I immunoreactivity
38. Glutamate receptor dysfunction and schizophrenia
39. Stereological quantitation of human brains from normal and schizophrenic individuals
40. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia
41. Crossed corticothalamic and thalamocortical connections of macaque prefrontal cortex
42. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenics
43. Reduced temporal lobe areas in schizophrenia: Preliminary evidences from a controlled multiplanar magnetic resonance imaging study
44. Abnormalities of the left temporal lobe and thought disorders in schizophrenia: A quantitative magnetic resonance imaging study
45. Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method
46. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
47. From neuropathology to neurodevelopment
48. Correlation between negative symptoms in schizophrenia with frontal lobe parameters on magnetic resonance imaging